Semaglutide is the once-weekly GLP-1 drug behind Ozempic and Wegovy
About 30 to 40 percent of patients experience some nausea during this phase, usually peaking 24 to 48 hours after injection and resolving within two to three days
Kidney Int 96(2):489504 Baartscheer A, Schumacher CA, Wst RC, Fiolet JW, Stienen GJ, Coronel R (2017) Zuurbier CJ Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
The FDA-approved labeling for semaglutide and tirzepatide does not list liver disease as a contraindication, and no dose adjustments are required for hepatic impairment
Semaglutide is usually administered once a week, and it can be injected into the abdomen, thigh, or upper arm
For some people, semaglutide might cause a mild to moderate histamine release, leading to itching